Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years

Journal of Travel Medicine

Volumn 18, Issue 2, 2011, Pages 145-148

  Chlibek, Roman ^a,e   Von Sonnenburg, Frank ^b   Van Damme, Pierre ^c   Smetana, Jan ^a   Tichy, Petr ^d   Gunapalaiah, Bhavyashree ^d   Leyssen, Maarten ^d   Jacquet, Jeanne Marie ^d  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF MUNICH   (Germany)

^c Vaccine and Infectious Disease Institute (WHO Collaborating Centre)   (Belgium)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^e UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL PROTOCOL; FEMALE; FOLLOW UP; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

ADULT; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; VACCINES, COMBINED;

EID: 79952266991     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2010.00499.x     Document Type: Article

References (11)

1. World Health Organization. International travel and health: situation as on 1 January. 2009. Available at: (Accessed 2010 July).
2. Cooper MC., The elderly travellers. Travel Med Infect Dis 2006; 4: 218-222. (Pubitemid 43677121)
3. Genton B, D'Acremont V, Furrer HJ, et al., Hepatitis A vaccines and the elderly. Travel Med Infect Dis 2006; 4: 303-312. (Pubitemid 44767191)
4. Sonder GJ., Hepatitis B vaccination in travellers. Expert Rev Vaccines 2008; 7: 673-677.
5. Costas L, Vilella A, Trilla A, et al., Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation. J Travel Med 2009; 16: 344-348.
6. Van der Wielen M, Van Damme P, Chlibek R, et al., Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine 2006; 24: 5509-5515. (Pubitemid 43831382)
7. Höhler T, Groeger-Bicanic G, Hoet B, Stoffel M., Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults. Vaccine 2007; 25: 1503-1508. (Pubitemid 46074289)
8. Van Herck K, Leroux-Roels G, Van Damme P, et al., Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrixâ¢) in adults. Travel Med Infect Dis 2007; 5: 171-175. (Pubitemid 46585955)
9. Wolters B, Müller T, Ross S, et al., Comparative evaluation of the immunogenicity of combined hepatitis A and B vaccine by a prospective and retrospective trial. Hum Vaccines 2009; 5: 248-253.
10. Van Damme P, Van Herck K., A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis 2007; 5: 79-84. (Pubitemid 46211211)
11. European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000; 355: 561-565.